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The mutagenic and antimutagenic activities of hexane, chloroform, ethyl acetate and methanol extracts from leaves of Myrtus communis, were
investigated by the Salmonella typhimurium assay. The different extracts showed no mutagenicity when tested with Salmonella typhimurium
strains TA98 and TA100 either with or without metabolic system (S9). On the other hand, each of the tested extracts exhibited a significant
protective effect against the mutagenicity induced by aflatoxin B1 (AFB1) in Salmonella typhimurium TA100 and TA98 assay systems, and
against the mutagenicity induced by sodium azide in TA100 and TA1535 assay system. Ethyl acetate and methanol extracts showed the highest
level of protection towards the direct mutagen, sodium azide, and indirect mutagen AFB1.
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Since ancient times, several diseases have been treated by
administration of plant extracts based on traditional medicine
(Pezzuto, 1997). Myrtus communis (Myrtaceae) a perennial
shrub, widely distributed in the Mediterranean area has been used
traditionally as an antiseptic and disinfectant drug. The essential
oil obtained from the leaves ismainly used in the treatment of lung
disorders (Gauthier et al., 1989) and has been found to possess
antibacterial (Chevolleau et al., 1993; Hayder et al., 2003), anti-
louse (Lauk et al., 1996) and antioxidant activities (Romani et al.,
2004).
Many plant species have been demonstrated to contain in large
amounts endogenous substances with mutagenic (Zani et al., 1991)
and antimutagenic properties (Calomme et al., 1996; Choi et al.,
1997; Lee et al., 2000; Park et al., 2004; Kilani et al., 2005; Bouhlel
et al., 2007; Ben Mansour et al., 2007; Ben Ammar et al., 2007).⁎ Corresponding author. Laboratoire de Biologie Moléculaire et Cellulaire,
Faculté de Médecine Dentaire de Monastir, Rue Avicenne, 5000 Monastir,
Tunisia. Tel.: +216 97 316282; fax: +216 73 461150.
E-mail addresses: leila.chekir@laposte.net, l_chekir@yahoo.fr
(L. Chekir-Ghedira).
0254-6299/$ - see front matter © 2007 SAAB. Published by Elsevier B.V. All righ
doi:10.1016/j.sajb.2007.10.001In this study, we report the antimutagenic effect of extracts
isolated from the leaves of Myrtus communis collected from
mountainous regions in Tunisia.
2. Materials and methods
2.1. Plant materials
M. communis var italica was collected from the National
Park of Boukornine in the north east of Tunisia, in November
1998. Identification was carried out by Pr. Chaieb (Department
of Botany, Faculty of Sciences. University of Sfax), according
to the flora of Tunisia (Pottier-Alapetite, 1978).
A voucher specimen has been kept in our laboratory for
future reference (M.c.11-98). The leaves were shade dried,
powdered and stored in a tightly closed container for further
use.
2.2. Plants extracts
The powdered leaves (200 g) were extracted by Soxhlet
apparatus for 6 h with successively 1.5 l of each of the following
solvents, hexane, chloroform, ethyl acetate and methanol tots reserved.
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polarities, were concentrated to dryness and the residues were
kept at 4 °C. Then, they were resuspended in Dimethyl-
Sulfoxide (DMSO). The yields of the extracts were respectively
4.6, 0.6, 2.4 and 28.66%.
2.3. Preliminary phytochemical analysis
Plant materials were screened for the presence of tannins,
flavonoids and coumarins, using the methods previously
described by Tona et al. (1998, 2004). Two mg of each extract
was separately dissolved in 2 ml of the adequate solvent. The
identification of major chemical groups was carried out by Thin
Layer Chromatography (TLC) on silica gel 60 F254 Merck
(layer thickness 0.25 mm) as follows; for flavonoids, TLC was
developed in n-butanol/acetic acid/water 4:1:5 (top layer), spots
were visualized with 1% aluminum chloride solution in
methanol under UV light 366 nm (Harborne, 1974). Coumarins
were detected under UV (366 nm) thanks to their blue
fluorescence which becomes intense after spraying 10%
potassium hydroxide solution in ethanol. The test for tannins
was carried out with FeCl3. Each class of tannins gave a specific
coloration.
2.4. Bacterial strains
Salmonella typhimurium strains TA100, TA98 and TA1535
which are histidine-requiring mutants, were kindly provided by
Pr. Quillardet, (Institut Pasteur de Paris, France), and maintained
as described by Maron and Ames (1983). The genotypes of the
test strains were checked routinely for their histidine requirement,
deep rough (rfa) character, UV sensitivity (uvr B mutation) and
presence of the R factor. They were stored at −80 °C.
S. typhimurium TA98 is frame shift sensitive strain which
contains, the hisD3052 mutation, as well as the plasmid pKM
101. In addition to encoding ampicilline resistance, this plasmid
encodes the muc AB genes products which enhance the SOS
mutagenesis (Maron and Ames, 1983). S. typhimurium TA1535
and TA100 strains contain the same base-pair substitution
mutation hisG46 (Zeiger et al., 1985).
S. typhimurium TA98, TA100 and TA1535 strains are known
to be more responsive to certain mutagens as AFB1 (for TA98
and TA100 strains) and sodium azide (for TA100 and TA1535
strains) (Maron and Ames, 1983).
2.5. Mutagens
Aflatoxin B1 (AFB1) was purchased from the Sigma
chemical CO., St. Louis, (USA) and dissolved in DMSO.
Sodium azide was purchased from the Aldrich chemical CO.,
Milwaukee, WI, (USA) and dissolved in distilled water.
2.6. Activation mixture
The S9 microsome fraction is prepared from the livers of rats
treated with Aroclor 1254 (Maron and Ames, 1983). The
components of S9 mix were 8 mM MgCl2, 33 mM KCl, 5 mMG6P, 4mMNADP, 0.1M sodium phosphate buffer, pH 7.4, and S9
fraction at a concentration of 0.04 ml/ml of mix. The S9 fraction
was stored at −80 °C.
2.7. Mutagenicity test
The test is based on the plate incorporation method (Maron
and Ames, 1983), using S. typhimurium test strains TA100 and
TA98, with and without an exogenous metabolic activation
system, the S9 fraction in S9 mix. The test strains from frozen
cultures were grown overnight for 12–16 h in oxoid nutrient
broth No. 2. Various concentrations of each extract dissolved in
DMSO were added to 2 ml of top agar, supplemented with
0.5 mM L-histidine and 0.5 mM D-biotine, mixed with 100 μl of
bacterial culture (approximate cell density 2–5×108 cells/ml)
and then poured on to a plate containing minimum agar
medium. The plates were incubated at 37 °C for 48 h and the
his+ revertant colonies were counted. The influence of
metabolic activation was tested by adding 500 μl of S9 mixture.
Negative and positive control cultures gave number of
revertants per plate that were within the normal limits found
in the laboratory. The criteria for a positive response were a
doubling for TA98 and TA100 strains and a tripling for TA1535
strain, of the relevant solvent control value (Maron and Ames,
1983; Marques et al., 2003). Data were collected with a mean±
standard deviation of three plates (n=3).
2.8. Antimutagenicity test
A modified plate incorporation procedure (Lee et al., 2000)
was employed to determine the effect of all extracts on AFB1
and sodium azide-induced mutagenicity. In brief, 0.5 ml of S9
mixture for indirect mutagen AFB1 and 0.5 ml of phosphate
buffer for direct mutagen sodium azide was distributed in
sterilized capped tubes in an ice bath, then 0.1 ml of test
compounds (50 μl of mutagen and/or 50 μl of test compound)
and 0.1 ml of bacterial culture (prepared as described in
mutagenicity test) were added. After vortexing gently and
preincubating at 37 °C for 45 min, 2 ml of top agar
supplemented with 0.5 mM L-histidine and D-biotine were
added to each tube and vortexed for 3 s. The resulting entire was
overlaid on the minimal agar plate. The plates were incubated at
37 °C for 48 h and the revertant bacterial colonies on each plate
were counted. The inhibition rate of mutagenicity (%) was
calculated relative to the number of revertant colonies in the
control group treated with the corresponding mutagen, by the
following equation:
Inhibition rate kð Þ
¼ ½1 ððnumber of revertants on test plates
number of spontaneous revertantsÞ
=ðnumber of revertants on mutagen control plates
number of spontaneous revertantsÞÞ  100:
Toxicity test for the different levels of samples were also
carried out, and the sample concentrations employed for
Table 2
Mutagenic activity of the Soxhlet extracts from Myrtus communis tested with
the Salmonella typhimurium TA100 and TA 98 assay systems
Treatment Concentration
μg/plate
Revertants per plate±SD
TA 100 TA 98
−S9 +S9 −S9 +S9
Spontaneous – 102±2 102±8 8±3 31±2
AFB1 0.3 455±25 359±12
Hexane extract 600 103±0 100±3 7±2 31±2
300 106±1 111±3 9±2 31±0
50 104±2 105±7 8±1 30±3
Chloroform extract 600 100±3 102±8 8±0 39±6
300 101±2 105±3 8±1 35±4
50 101±3 100±8 9±3 34±3
Ethyl acetate extract 600 106±3 103±4 7±2 36±6
300 104±1 107±8 8±2 33±3
50 108±6 100±3 7±1 31±1
Methanol extract 600 105±3 102±4 8±2 38±2
300 107±2 100±3 8±0 37±3
50 108±3 101±0 9±1 34±4
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Each dose was tested in triplicate.
3. Results
The preliminary chemical compositions of the tested extracts
are shown in Table 1. Methanol extract showed the presence of
higher quantities of flavonoids and tannins than ethyl acetate
extract, whereas they contain almost the same content of
coumarins. The chloroform extract contains just a weak quantity
of flavonoids.
Likewise, previous phytochemical screening of Myrtus
communis evidenced the presence of flavonoids, tannins and
coumarins (Diaz and Abeger, 1987; Hinou et al., 1988). No
mutagenicity was detected with hexane, chloroform, ethyl
acetate and methanol extracts, derived from the leaves of
Myrtus communis, when assessed by the Salmonella typhimur-
ium assay in the presence of the TA98 and TA100 strains, either
with or without the metabolic activation system (S9).
Concentrations of 50, 300 and 600 μg dry weight of each
extract par plate did not increase the revertant number tow-fold
above those obtained in absence of the extract (spontaneous
revertants).
Results of the antimutagenicity assay using AFB1 (0.3 μg/
plate with S9) as the mutagenic agent are shown in Table 3.
Hexane and chloroform extracts showed a significant but lower
dose-dependent antimutagenic activity, in both Salmonella
typhimurium TA100 and TA98 systems when compared to
ethyl acetate and methanol extracts. In fact 600 μg/plate of ethyl
acetate and methanol extracts are able to inhibit totally the AFB1
induced mutagenicity in Salmonella typhimurium TA98 assay
system and by respectively 95 and 93% in TA100 assay system.
Myrtus communis extract antimutagenicity was also
evaluated against the directly acting sodium azide (1.5 μg/
plate) mutagen in both S. typhimurium TA1535 and TA100
assay system (Table 4). The results obtained confirm that ethyl
acetate and methanol extracts are more effective in reducing
sodium azide mutagenicity than hexane and chloroform
extracts. This difference is more detectable in the presence
of Salmonella typhimurium TA100 assay system.
4. Discussion
Traditional use of plants in alternative medicine frequently
provides the basis to select which plant extract it is worth
studying. Extracts of Myrtus communis have been used
extensively in the Mediterranean areas, to treat many types ofTable 1
Phytochemical screening of extracts from Myrtus communis
Extract Yield (% W/W) Tannins Flavonoids Coumarins
Hexane extract 4.6 − − −
Chloroform extract 0.6 − + −
Ethyl acetate extract 2.4 ++ ++ ++
Methanol extract 28.66 ++++ ++++ ++
− Absent, + low quantities, ++ high quantities, ++++ very high quantities.infectious diseases and as antiseptic and anti-inflammatory
agent. These characteristics make them a good therapeutic
prospect of study.
Our purpose was to investigate the possible mutagenic and
antimutagenic properties of M. communis extracts with the
Ames assay. Results obtained with TA98 strain, for frame shift
mutation and TA100 strain for base-pair substituents, showed
that the four tested extracts are not mutagenic, in the Ames
assay since even at high concentration it did not induce increase
in number of revertants when compared to the number of
spontaneous revertants, either alone or in the presence of S9
(Table 2).
The absence of mutagenicity is not a characteristic of all
natural products in use, since other medicinal plants assayed
with the Ames test, with or without the S9, have resulted
positive for mutagenicity (Hyun et al., 1987; Sohni et al., 1995;
Anderson et al., 1997).
Results of antimutagenic activities showed that ethanol and
ethyl acetate extracts were highly effective in reducing the
mutagenicity caused by the indirect mutagen AFB1. Whereas
chloroform and hexane extracts exhibited lower antimutagenic
activity against AFB1 (Table 3). Methanol and ethyl acetate
extracts showed stronger antimutagenic activity towards
sodium azide in TA100 assay system, when compared to
chloroform and hexane extracts tested in the same assay system
(Table 4).
Methanol and ethyl acetate extracts exhibited almost the
same level of antimutagenicity towards the directly acting
mutagen sodium azide in the TA1535 assay system, when
compared to chloroform and hexane extracts.
As far as, methanol and ethyl acetate extracts contain mainly
phenolic compound including tannins, flavonoids and coumar-
ins (Table 1), our results confirm the data previously reported on
the antimutagenic properties of these compounds (Calomme
et al., 1996; Okuda et al., 1989; Lee et al., 2000).
Table 3
Inhibition of the mutagenicity of AFB1 (0.3 μg/plate), induced in the presence of S9, by the soxhlet extracts obtained from Myrtus communis, in Salmonella
typhimurium TA100 and TA98 assay systems
Treatment Concentration
μg/plate
TA 98 TA 100
Number of revertants
per plate±SD
% inhibition of
mutagenesis
Number of revertants
per plate±SD
% inhibition of
mutagenesis
Spontaneous – 39±7 93±10
AFB1 0.3 450±12 415±25
Hexane extract 50 327±7 29.92 341±13 22.98
300 225±6 54.74 290±7 38.81
600 204±10 60 251±6 51
Chloroform extract 50 368±7 19.95 316±6 30.74
300 225±10 54.74 282±7 41.30
600 205±6 60 271±7 45
Ethyl acetate
extract
50 155±8 71.77 164±7 77.95
300 109±3 82.96 132±6 87.88
600 38±8 100 108±3 95
Methanol extract 50 183±8 64.96 203±8 65.83
300 118±3 80.77 131±6 88.19
600 39±10 100 116±3 93
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process by hepatic microsomal cytochrome P450 and successive
epoxide hydrolysis and glutathione conjugation. The epoxide and
other intermediates substitute for the nitrogens of nucleic acid in
DNA strands and cleave DNA strands to cause mutagenicity.
Moreover, several metabolic intermediates and reactive oxygen
species (ROS) formed during the process of microsomal enzyme
activation are also capable of breaking DNA strands. In contrast,
sodium azide requires no activation by hepatic microsomal
enzymes to damage DNA and induce mutagenicity. The
methanolic and ethyl acetate extracts exhibited significant
antimutagenicity towards the sodium azide-induced mutagenicity
as well as towards the AFB-1-induced one. This suggests that
these extracts may inhibit microsomal enzyme activation or thatTable 4
Inhibition of the mutagenicity of sodium azide (1.5 μg/plate), without S9, by the soxh
and TA1535 assay systems
Treatment Concentration
μg/plate
TA 1535
Number of revertants
per plate±SD
Spontaneous – 14±1
Sodium azide 1.5 140±10
Hexane extract 50 92±3
300 69±7
600 46±4
Chloroform extract 50 89±9
300 83±3
600 43±7
Ethyl acetate extract 50 66±7
300 63±8
600 42±9
Methanol extract 50 58±2
300 55±3
600 40±7they may directly protect DNA strands from the electrophilic
metabolites of the mutagen. However, the inhibition of
mutagenesis is often complex, acting through multiple mechan-
isms (Kada, 1993). The inhibition of the P 450 mono-oxygenase
system is known to operate in the antimutagenic effects of some
plants extracts (Zani et al., 1993) on the mutagen AFB1 and, we
suspect also, in the antimutagenic activity of the extracts of
Myrtus communis. The results suggest that methanolic and ethyl
acetate extracts have a protective effect against the mutagenicity
induced by both AFB-1 and sodium azide.
These features make Myrtus communis leaves extracts
promising candidates for further studies designed to obtain
more evidence on their components with potential chemopre-
ventive activity.let extracts obtained fromMyrtus communis, in Salmonella typhimurium TA100
TA 100
% inhibition of
mutagenesis
Number of revertants
per plate±SD
% inhibition of
mutagenesis
100±10
405±20
38.09 315±14 29.50
56.34 214±3 62.62
75 208±4 65
42.85 250±10 50.81
45.23 213±7 62.95
77 201±7 67
58.73 160±7 80.32
61.11 132±8 89.50
78 123±6 94
65.07 157±8 81.31
67.46 120±5 93.44
79 119±9 92
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